Literature DB >> 29740794

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys).

Masaru Sasaki1, Tetsuhiko Yasuno2, Kenji Ito1, Akira Matsunaga3, Satoshi Hisano4, Yasuhiro Abe1, Katsuhisa Miyake1, Kosuke Masutani1, Hitoshi Nakashima1, Takao Saito5.   

Abstract

Apolipoprotein (apo) E5 is a rare apoE isoform. The apoE5 (Glu3Lys) variant, which is caused by the substitution of lysine with glutamic acid at codon 3, has a relative frequency of 0.1% in Japan. Previous studies have reported that apoE5 (Glu3Lys) is associated with hyperlipidemia and cardiovascular diseases, but this isoform has higher LDL receptor-binding activity than that of normal apoE3. Nephropathy associated with apoE5 (Glu3Lys) alone has not yet been reported. We present a case of a 51-year-old man with nephrotic syndrome. On renal biopsy, three glomeruli showed segmental sclerosis with hypertrophy of podocytes and intracapillary marked infiltration of intraglomerular foam cells. These findings were compatible with focal segmental glomerulosclerosis (FSGS). The patient had mild diabetes mellitus and monoclonal gammopathy of undetermined significance, but there were no specific findings of nephrolopathy related to these diseases. Various factors are involved in the pathogenesis of FSGS, including dyslipidemia and apoE activity. Our findings suggest that abnormal lipid metabolism by ApoE5 (Glu3Lys) is involved in the onset of FSGS.

Entities:  

Keywords:  ApoE isoform; Foam cells; Hyperlipidemia; Podocyte injury; Variant

Mesh:

Substances:

Year:  2018        PMID: 29740794      PMCID: PMC6181881          DOI: 10.1007/s13730-018-0331-4

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

Review 1.  Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Authors:  Takao Saito; Akira Matsunaga; Shinichi Oikawa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

Review 2.  Mechanisms of disease: focal segmental glomerulosclerosis.

Authors:  Alain Meyrier
Journal:  Nat Clin Pract Nephrol       Date:  2005-11

3.  A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I.

Authors:  Satoshi Takasaki; Akira Matsunaga; Kensuke Joh; Takao Saito
Journal:  CEN Case Rep       Date:  2018-01-22

4.  Contribution of mononuclear leucocytes to the progression of experimental focal glomerular sclerosis.

Authors:  T Saito; R C Atkins
Journal:  Kidney Int       Date:  1990-04       Impact factor: 10.612

5.  Enhanced binding activity of an apolipoprotein E mutant, APO E5, to LDL receptors on human fibroblasts.

Authors:  L M Dong; T Yamamura; A Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

6.  Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3----Lys) and its binding to low density lipoprotein receptors.

Authors:  L M Dong; T Yamamura; S Tajima; A Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

7.  Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis.

Authors:  T Saito; T Ootaka; H Sato; T Furuta; T Sato; J Soma; K Abe; K Yoshinaga
Journal:  J Pathol       Date:  1993-06       Impact factor: 7.996

Review 8.  Focal and segmental glomerulosclerosis: analogies to atherosclerosis.

Authors:  J R Diamond; M J Karnovsky
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

9.  Population frequency of apolipoprotein E5 (Glu3-->Lys) and E7 (Glu244-->Lys, Glu245-->Lys) variants in western Japan.

Authors:  A Matsunaga; J Sasaki; K Moriyama; F Arakawa; Y Takada; K Nishi; K Hidaka; K Arakawa
Journal:  Clin Genet       Date:  1995-08       Impact factor: 4.438

10.  Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Maurizio Bruschi; Paolo Catarsi; Giovanni Candiano; Maria Pia Rastaldi; Luca Musante; Francesco Scolari; Mary Artero; Michele Carraro; Alba Carrea; Gianluca Caridi; Cristina Zennaro; Simone Sanna-Cherchi; Fabio Battista Viola; Franco Ferrario; Francesco Perfumo; Gian Marco Ghiggeri
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

View more
  4 in total

Review 1.  Apolipoprotein E and Atherosclerosis.

Authors:  A D Marais
Journal:  Curr Atheroscler Rep       Date:  2021-05-10       Impact factor: 5.113

2.  Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Authors:  Jianyong Zhong; Jacob B Whitman; Hai-Chun Yang; Agnes B Fogo
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 3.  An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.

Authors:  Meng-Shi Li; Yang Li; Yang Liu; Xu-Jie Zhou; Hong Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-06

Review 4.  Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.

Authors:  Pei-Hui Lin; Pu Duann
Journal:  Front Physiol       Date:  2020-09-03       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.